Tyche Industries Ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 532384
₹106.55
▲ 2.15 (2.06%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
52/100
Moderate
Valuation
70/100
Undervalued
Momentum
47/100
Neutral

QVM read Cheap on its own multiples Quality Moderate, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹109 Cr
PE (TTM)
24.9
Industry median 36.1 (152 companies)
Price to Book
0.8
PEG (TTM)
-0.4
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-47.2
Free Cash Flow
₹-1 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
-101.69%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
-31.87%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
-21.02%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
-61.59%
as of Dec. 31, 2025
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
-28.35%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
16.46
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
61511.00
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
7.13%
as of March 31, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
-0.59%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
12.29%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
6.24%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
6.69%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
6.58%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • No Return on equity is 15% or more (6.6%)
  • No Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

2 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
2.1%
Low 104.0500 · High 109.9500
1W return
-2.9%
Low 102.8500 · High 109.9500
1M return
0.0%
Low 102.8500 · High 118.9500
52W return
-47.2%
Low 101.2500 · High 132.4000
Lifetime High ₹339.4000 (Aug. 21, 2020)
Lifetime Low ₹6.9000 (Oct. 27, 2008)

Full price history and technicals →

EMA & SMA

Bullish1
Bearish5
5D
106.4
10D
107.6
20D
109.7
50D
124.6
100D
144.1
200D
170.1

Delivery and volume

Day avg. delivery
68.1%
Week avg. delivery
79.6%
Month avg. delivery
64.2%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

106.85
Pivot
First resistance109.65
Second resistance112.75
Third resistance115.55
First support103.75
Second support100.95
Third support97.85
Day RSI40.5
Day MFI74.7
Day MACD-4.16
Day MACD signal-5.00

Beta

1M1.07
3M0.80
1Y0.80
3Y0.66

Price change analysis

↑ 0.0%
Over 1 Month
LowHigh
102.85118.95
↓ -47.2%
Over 3 Months
LowHigh
101.25132.40
↓ -47.2%
Over 6 Months
LowHigh
101.25132.40
↓ -47.2%
Over 1 Year
LowHigh
101.25132.40
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 24.9 (own history: 14.2–47.2)
Buy Zone
Revenue (June 30, 2026)
₹9 Cr
Net profit (June 30, 2026)
₹— Cr
Basic EPS (June 30, 2026)
₹-0.0400

Ranks #137 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter61.97%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 61.97% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
10 Oct 2017 GARNET INTERNATIONAL LIMITED Bulk Buy 63,000 116.2000 BSE
17 May 2016 ONKAR SINGH Bulk Buy 53,187 70.2200 BSE
24 Mar 2015 NARENDRA GUPTA Bulk Sell 60,000 20.9500 BSE
24 Mar 2015 SAMIR NARENDRA GUPTA Bulk Buy 60,000 20.9500 BSE
27 Dec 2012 NARENDRA GUPTA Bulk Buy 52,000 13.8300 BSE
27 Dec 2012 SAMIR NARENDRA GUPTA Bulk Sell 52,100 13.8300 BSE
28 Mar 2011 DEEPINDER SINGH POONIAN Bulk Sell 73,375 13.3100 BSE
21 Dec 2010 SAROJ PODDAR Bulk Sell 50,000 17.0000 BSE
21 Dec 2010 LALIT KUMAR PODDAR Bulk Buy 50,000 17.0000 BSE
3 Dec 2010 LEENA SHASHIKANTBHAI SHAH Bulk Sell 49,100 18.2200 BSE

All bulk and block deals →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Siris Soft Ltd. to Tyche Industries Ltd.

All corporate actions →

Corporate Announcements

All 5 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 AGM/EGM Tyche Industries Ltd - 532384 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
30 Sep 2026 AGM/EGM Tyche Industries Ltd - 532384 - Shareholder Meeting / Postal Ballot-Outcome of AGM
5 Sep 2026 Company Update Tyche Industries Ltd - 532384 - Corrigendum To The Annual Report For The Financial Year 2025-26
2 Sep 2026 Corp. Action Tyche Industries Ltd - 532384 - Intimation Of Record Date For The Purpose Of Payment Of Final Dividend For The F.Y. 2025-26.
2 Sep 2026 Corp. Action Tyche Industries Ltd - 532384 - Intimation Of Book Closure For 28Th Annual General Meeting

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.00)
  • Comfortable interest coverage (61511.0x)

Weaknesses

  • Low Return on Equity (6.6%)
  • Declining revenue YoY (-28.4%)
  • Declining profit YoY (-61.6%)

Opportunities

  • Trading below book value (PB 0.78)

Threats

  • Down 47.2% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Tyche Industries Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.